Vaccines

19 Mar 2016 AXON Presented Its Tau Vaccine in Two Presentations at 14Th AAT Conference
17 Mar 2016 Vaxon Biotech completes enrollment of phase 2b lung cancer trial of first therapeutic vaccine based on optimized cryptic peptides
16 Mar 2016 Trials of a New Vaccine for Ebola to Take Place at RUSAL's Medical Centre in Guinea
16 Mar 2016 Publication in Retrovirology of the results of Biosantech's phase IIA clinical trial for the anti-HIV candidate vaccine
10 Mar 2016 Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer
10 Mar 2016 Medigene AG: Data and Safety Monitoring Board recommends advance of current DC vaccine clinical trial in AML into Phase II
07 Mar 2016 Data Safety and Monitoring Board Recommends Celldex's Phase 3 Study of RINTEGA® (rindopepimut) in Newly Diagnosed Glioblastoma be Discontinued as it is Unlikely to Meet Primary Overall Survival Endpoint in Patients with Minimal Residual Disease
07 Mar 2016 Stallergenes Greer Presents Findings from Four Allergy Immunotherapy Studies at the 2016 AAAAI Annual Meeting
07 Mar 2016 Aimmune Therapeutics Announces Phase 2 Follow-On Study of AR101 for the Treatment of Peanut Allergy Demonstrated Increased Desensitization and Improved Tolerability with Low-Dose Maintenance
03 Mar 2016 Immunovaccine Initiates Zika Virus Vaccine Program Using Proprietary DepoVax(TM) Platform
03 Mar 2016 Vaxart Begins Preclinical Testing of an Oral Zika Virus Vaccine
23 Feb 2016 OncBioMune Continuing Phase 1 Trial, While Initiating Phase 2 Trial of ProscaVax for Prostate Cancer
23 Feb 2016 OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer
23 Feb 2016 OSE Pharma SA: First patients enrolled and dosed in the pivotal trial of Phase 3 of the immunotherapy Tedopi® for advanced non-small cell lung cancer
23 Feb 2016 OncoQR ML's Pancreatic Cancer Vaccine TYG100 Induces Clinically Relevant Immune Response Within Just 2 Weeks After Single Vaccination
19 Feb 2016 Phase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study Groups
18 Feb 2016 NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus
18 Feb 2016 VALNEVA Evaluating Development of Zika Vaccine as Virus Spreads Through the Americas
17 Feb 2016 Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses in Preclinical Study
17 Feb 2016 Bharat Biotech Unveils ZIKAVAC® First Vaccine Candidate for Zika Virus
10 Feb 2016 Myasthenia gravis: CuraVac launches phase 1b study in patients
09 Feb 2016 Immune Design Announces Positive Topline Data From Three Phase 1 Clinical Trials of Immuno-oncology Product Candidates
05 Feb 2016 Novel cancer vaccine in combination with check point blockades holds promise
02 Feb 2016 Telesta Therapeutics Receives Complete Response Letter from FDA
02 Feb 2016 Sanofi Pasteur to leverage its strong vaccine legacy in hunt for Zika vaccine

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top